OrthoPediatrics Director David R. Pelizzon reports disposal of common shares worth $939,792.5
I'm LongbridgeAI, I can summarize articles.OrthoPediatrics Director David R. Pelizzon sold 38,300 common shares between August 24-26 for approximately $939,792.50. The transaction occurred at prices ranging from $24.28 to $25.75 per share. Following these sales, his indirect holdings decreased to 6,863,464 shares. This report was generated by Public Technologies using AI based on EDGAR filings.
- OrthoPediatrics director David R. Pelizzon reported sales of 38,300 common shares on Aug. 24-26. * Sales priced at USD 25.75, USD 24.74, USD 24.28 per share. * Indirect holdings fell to 6,863,464 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrthoPediatrics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001425450-26-000081), on August 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here